Clinical Trials Logo

Clinical Trial Summary

The Missed Period Pill Study is a prospective observational study among people who decide to use misoprostol alone for menstrual regulation.


Clinical Trial Description

As the number of state laws restricting access to abortion increases across the country, more creative methods are needed to support individuals in achieving their reproductive goals. Misoprostol alone for people who suspect, but have not confirmed pregnancy, has the potential to fulfill this growing need. The goal of this research study is to test a traditional but underutilized framework of menstrual regulation for pregnancy loss, to "bring back" a period when it is missed. This study will aim to recruit 100 patients who have a missed period to address research questions that focus on the feasibility and acceptability of using misoprostol alone for menstrual regulation. The study will require 1 study visit and 1 telehealth visit. First study visit: A urine sample will be collected which will later undergo pregnancy testing. Participants will be given misoprostol along with instructions and information on what to expect. The participant will be required to return to the clinic 4 weeks later to provide another urine sample. The participant will not know the results of the first visit's pregnancy test at any point. The clinic staff member administering the participant's care will not know of the pregnancy test result while the participant is at the clinic. Telehealth visit: The second visit will be by phone or video. The participant will conduct a pregnancy test and inform the research staff of the result. The participant will then be asked to answer questions on an online survey about their experience using misoprostol. A variety of clinical and social science measures will be collected to assess the feasibility and acceptability of this traditional concept of menstrual regulation utilizing uterine evacuation with medications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04940013
Study type Interventional
Source University of California, San Francisco
Contact Ushma Upadhyay, PhD, MPH
Phone 510-986-8946
Email ushma.upadhyay@ucsf.edu
Status Recruiting
Phase Phase 4
Start date October 25, 2021
Completion date September 2024

See also
  Status Clinical Trial Phase
Completed NCT05688995 - COVID-19 Vaccines and the Menstrual Cycle
Completed NCT01927471 - Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Completed NCT00392873 - Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity N/A
Completed NCT05083065 - Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
Completed NCT03547453 - Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
Completed NCT04985591 - The Effect of Liposuction on Menses: a Retrospective Study Early Phase 1
Completed NCT06339476 - Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers N/A
Completed NCT04006171 - Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women N/A
Completed NCT01555190 - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone N/A
Active, not recruiting NCT05230316 - Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
Completed NCT05410314 - Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma
Withdrawn NCT05518006 - An Investigation of Premama Balance and Its Effects on Hormonal Imbalances N/A
Not yet recruiting NCT05224726 - Platelet Rich Plasma for Uterine Scar N/A
Completed NCT04413058 - Menstrual Cycle Characteristics of Healthcare Professionals
Recruiting NCT05197491 - Women's Menstruation During the Covid-19 Pandemic